# EDGAR Filing Document

**Accession Number:** 0001056358
**File Stem:** 0001056358-25-000070
**Filing Date:** 2025-7
**Character Count:** 4902
**Document Hash:** 8e04e9742e72352c55d735549b63fcd4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001056358-25-000070.hdr.sgml**: 20250724

**ACCESSION NUMBER**: 0001056358-25-000070

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20250724

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**FILED AS OF DATE**: 20250724

**DATE AS OF CHANGE**: 20250724

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MANNATECH INC
- **CENTRAL INDEX KEY:** 0001056358
- **STANDARD INDUSTRIAL CLASSIFICATION:** MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 752508900
- **STATE OF INCORPORATION:** TX
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-24657
- **FILM NUMBER:** 251147090

**BUSINESS ADDRESS:**
- **STREET 1:** 1410 LAKESIDE PARKWAY
- **STREET 2:** SUITE 200
- **CITY:** FLOWER MOUND
- **STATE:** TX
- **ZIP:** 75028
- **BUSINESS PHONE:** 9724717400

**MAIL ADDRESS:**
- **STREET 1:** 1410 LAKESIDE PARKWAY
- **STREET 2:** SUITE 200
- **CITY:** FLOWER MOUND
- **STATE:** TX
- **ZIP:** 75028

?xml version='1.0' encoding='ASCII'? mtex-20250724

 **UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): July 24, 2025

**MANNATECH, INCORPORATED**

(Exact Name of Registrant as Specified in its Charter)

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Texas** | **000-24657** | **000-24657** | **75-2508900** | **75-2508900** |
| (State or other jurisdiction of incorporation) | (Commission File Number) | (Commission File Number) | (IRS Employer Identification No.) | (IRS Employer Identification No.) |
| **1410 Lakeside Parkway, Suite 200** | **1410 Lakeside Parkway, Suite 200** | **1410 Lakeside Parkway, Suite 200** | **1410 Lakeside Parkway, Suite 200** |  |
| **Flower Mound,** | **Texas** | **75028** | **75028** |  |
| (Address of Principal Executive Offices, including Zip Code) | (Address of Principal Executive Offices, including Zip Code) | (Address of Principal Executive Offices, including Zip Code) | (Address of Principal Executive Offices, including Zip Code) |  |
| Registrant's Telephone Number, including Area Code: | Registrant's Telephone Number, including Area Code: | Registrant's Telephone Number, including Area Code: | **(972)** | **471-7400** |

---

(**Former name or former address, if changed since last report**.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to <u>Rule 425 under the Securities Act (17 CFR 230.425)</u>

[ ] Soliciting material pursuant to <u>Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</u>

[ ] Pre-commencement communications pursuant to <u>Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</u>

[ ] Pre-commencement communications pursuant to <u>Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</u>

Securities Registered Pursuant to Section 12(b) of the Act:

---

| | | | |
|:---|:---|:---|:---|
| Title of each class | Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock, | par value $0.0001 per share | MTEX | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging Growth Company ◻

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □

------

**Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers**

On July 21, 2025 Mannatech, Incorporated and its Board of Directors were notified by Peter Griscom, the Company's Chief Operating Officer, of his resignation from his position effective August 8, 2025.

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: July 24, 2025

---

| | |
|:---|:---|
| **MANNATECH, INCORPORATED** | **MANNATECH, INCORPORATED** |
| By: | ***/s/ Landen Fredrick*** |
|  | Landen Fredrick |
|  | Chief Executive Officer |

---